Last reviewed · How we verify
CSCC_ASC
At a glance
| Generic name | CSCC_ASC |
|---|---|
| Also known as | Cardiology Stem Cell Centre_adipose derived stem cells |
| Sponsor | JKastrup |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease (EARLY_PHASE1)
- Allogeneic Stem Cell Therapy in Heart Failure (PHASE2)
- Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation (PHASE1, PHASE2)
- Stem Cell Therapy in Non-IschEmic Non-treatable Dilated CardiomyopathiEs II: a Pilot Study (PHASE1, PHASE2)
- Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease (PHASE2)
- CSCC_ASC Therapy in Patients With Severe Heart Failure (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |